The project of the Research and Development Center of Chongqing Medical Engineering Institute Pharmaceutical Research Co., Ltd. (Phase One) has been completed.
Source:
Public Announcement of the Environmental Protection Acceptance Report for the R&D Center Project of Chongqing Medical Engineering Institute Pharmaceutical Research Co., Ltd. (Phase One) Completion
On December 19, 2019, Chongqing Medical Engineering Institute Pharmaceutical Research Co., Ltd. organized a completion environmental protection acceptance meeting, attended by Chongqing Huan Ke Yuan Bo Da Environmental Technology Co., Ltd. (report preparation unit), Chongqing Xia Mei Environmental Technology Co., Ltd. (monitoring unit), Chongqing De He Environmental Engineering Co., Ltd. (environmental engineering construction unit), and three environmental protection experts. The acceptance team conducted an on-site inspection, concluding that "after on-site inspection, the environmental protection approval procedures and environmental protection documentation for the R&D Center Project of Chongqing Medical Engineering Institute Pharmaceutical Research Co., Ltd. (Phase One) are complete, and environmental management regulations have been established. The project's environmental protection facilities and management measures have been implemented in accordance with the environmental impact assessment and approval requirements, all environmental protection facilities are operating normally, and the pollutants discharged meet the acceptance standards. The project meets the acceptance conditions and is approved for environmental protection acceptance."
According to the "Interim Measures for the Environmental Protection Acceptance of Construction Projects Completion", after the acceptance report is completed, it should be made public through the website or other means convenient for the public to know. The "Environmental Protection Acceptance Report for the R&D Center Project of Chongqing Medical Engineering Institute Pharmaceutical Research Co., Ltd. (Phase One)" is now announced. The public can submit opinions to our unit by phone (please provide detailed contact information when submitting opinions so that we can promptly respond to you).
The acceptance report consists of three parts: acceptance monitoring (investigation) report, acceptance opinions, and other matters that need explanation. Download link 【Link:https://pan.baidu.com/s/1TTKdFf61rlWxAB1DPCWtIwExtraction code: n832】
Contact person: Yin Shijuan 18282582894.
Public announcement period: 20 working days from the date of announcement.
Chongqing Medical Engineering Institute Pharmaceutical Research Co., Ltd.
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
